Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.68

€0.68

1.610%
0.011
1.610%
-

-

 
18.04.24 / Tradegate WKN: A14R2R / Name: Cidara / Stock / Biotechnology & Medical Research / Micro Cap /

Cidara Therapeutics Inc Stock

There is an upward development for Cidara Therapeutics Inc compared to yesterday, with an increase of €0.011 (1.610%).
Our community identified positive and negative aspects for Cidara Therapeutics Inc stock for the coming years. 1 users see the criterium "Revenue growth" as a plus for the Cidara Therapeutics Inc stock. On the other hand our users think that "Company culture" could be a problem in the future.

Pros and Cons of Cidara Therapeutics Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cidara Therapeutics Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cidara Therapeutics Inc 1.610% -15.584% 5.324% -33.480% -7.143% -61.872% -
Jaguar Health Inc. 6.940% 67.068% 160.000% 112.788% 10.199% -99.931% -
Vaxart Inc. -0.370% -18.135% -26.306% 25.040% 53.220% -82.323% -
aTyr Pharma Inc 3.380% -4.969% -17.297% -12.069% 18.605% -49.000% -76.698%

Comments

Buy Cidara Therapeutics Inc
Show more